UNODC. World Drug Report 2013. United Nations Publication Vienna, 2013.
Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2013 National Survey on Drug Use and Health: Summary of national findings. Substance Abuse and Mental Health Servicels Administration, Rockville, MD, 2014.
Google Scholar
Elsohly MA, Slade D. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 2005;78:539-548.
CAS
PubMed
Article
Google Scholar
Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacother 2013;33:195-209.
CAS
Article
Google Scholar
McPartland JM, Duncan M, Di Marzo V, Pertwee RG. Are cannabidiol and Delta(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharmacol 2015;172:737-753.
CAS
PubMed
PubMed Central
Article
Google Scholar
Benbadis SR, Sanchez-Ramos J, Bozorg A, et al. Medical marijuana in neurology. Exp Rev Neurother 2014;14:1453-1465.
CAS
Article
Google Scholar
Mackie K. Signaling via CNS cannabinoid receptors. Mol Cell Endocrinol 2008;286:S60-S65.
PubMed Central
CAS
PubMed
Article
Google Scholar
Pertwee R. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin. Br J Pharmacol 2008;153:199-215.
PubMed Central
CAS
PubMed
Article
Google Scholar
Pertwee RG. Cannabinoid pharmacology: the first 66 years. Br J Pharmacol 2006;147(Suppl. 1):S163-S171.
PubMed Central
CAS
PubMed
Google Scholar
Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003;4:873-884.
CAS
PubMed
Article
Google Scholar
Pertwee R. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem 2010;17:1360.
PubMed Central
CAS
PubMed
Article
Google Scholar
Suarez-Pinilla P, Lopez-Gil J, Crespo-Facorro B. Immune system: a possible nexus between cannabinoids and psychosis. Brain Behav Immun 2014;40:269-282.
CAS
PubMed
Article
Google Scholar
Machado Bergamaschi M, Helena Costa Queiroz R, Waldo Zuardi A, Crippa AS. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf 2011;6:237-249.
Article
Google Scholar
Pope C, Mechoulam R, Parsons L. Endocannabinoid signaling in neurotoxicity and neuroprotection. Neurotoxicology 2010;31:562-571.
PubMed Central
CAS
PubMed
Article
Google Scholar
Schatman ME. Medical Marijuana: the state of the science. Medscape Neurology [Internet] 2015. [cited 2015 April 20]. Available from: http://www.medscape.com/viewarticle/839155
Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996;91:1585-11614.
CAS
PubMed
Article
Google Scholar
Cascini F, Aiello C, Di Tanna G. Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis. Curr Drug Abuse Rev 2012;5:32-40.
CAS
PubMed
Article
Google Scholar
Fitzgerald KT, Bronstein AC, Newquist KL. Marijuana poisoning. Top Companion Anim Med 2013;28:8-12.
PubMed
Article
Google Scholar
McLaren J, Swift W, Dillon P, Allsop S. Cannabis potency and contamination: a review of the literature. Addiction 2008;103:1100-1109.
PubMed
Article
Google Scholar
Repp K, Raich A. Marijuana and health: a comprehensive review of 20 years of research. Washington County Oregon: Department of Health and Human Services; 2014.
Robson P. Human studies of cannabinoids and medicinal cannabis. Handb Exp Pharmacol 2005;(168):719-786.
CAS
PubMed
Article
Google Scholar
Scallet AC. Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals. Pharmacol Biochem Behav 1991;40:671-676.
CAS
PubMed
Article
Google Scholar
Wall ME, Sadler BM, Brine D, Taylor H, Perez‐Reyes M. Metabolism, disposition, and kinetics of delta‐9‐tetrahydrocannabinol in men and women. Clin Pharmacol Ther 1983;34:352-363.
CAS
PubMed
Article
Google Scholar
Zuurman L, Ippel AE, Moin E, Van Gerven J. Biomarkers for the effects of cannabis and THC in healthy volunteers. Br J Clin Pharmacol 2009;67:5-21.
PubMed Central
CAS
PubMed
Article
Google Scholar
Zuurman L, Passier P, de Kam M, Kleijn H, Cohen A, van Gerven J. Pharmacodynamic and pharmacokinetic effects of the intravenously administered CB1 receptor agonist Org 28611 in healthy male volunteers. J Psychopharmacol 2009;23:633-644.
CAS
PubMed
Article
Google Scholar
Grotenhermen F. The toxicology of cannabis and cannabis prohibition. Chem Biodivers 2007;4:1744-1769.
CAS
PubMed
Article
Google Scholar
Hall W. The adverse health effects of cannabis use: what are they, and what are their implications for policy? Int J Drug Policy 2009;20:458-466.
PubMed
Article
Google Scholar
Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;374:1383-1391.
CAS
PubMed
Article
Google Scholar
Reece AS. Chronic toxicology of cannabis. J Clin Toxicol 2009;47:517-524.
CAS
Article
Google Scholar
Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol 2014;113:187-190.
CAS
PubMed
Article
Google Scholar
Kahan M, Srivastava A, Spithoff S, Bromley L. Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations. Can Fam Physician 2014;60:1083-1090.
PubMed Central
PubMed
Google Scholar
Parakh P. Adverse health effects of non-medical cannabis use. Lancet 2010;375:196-197.
PubMed
Article
Google Scholar
Tormey W. Adverse health effects of non-medical cannabis use. Lancet 2010;375:196.
PubMed
Article
Google Scholar
Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med 2014;370:2219-2227.
PubMed
Article
CAS
Google Scholar
Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:849-863.
CAS
PubMed
Article
Google Scholar
Hashibe M, Straif K, Tashkin DP, Morgenstern H, Greenland S, Zhang ZF. Epidemiologic review of marijuana use and cancer risk. Alcohol 2005;35:265-275.
CAS
PubMed
Article
Google Scholar
Maertens RM, White PA, Williams A, Yauk CL. A global toxicogenomic analysis investigating the mechanistic differences between tobacco and marijuana smoke condensates in vitro. Toxicology 2013;308:60-73.
CAS
PubMed
Article
Google Scholar
Gates PJ, Albertella L, Copeland J. The effects of cannabinoid administration on sleep: a systematic review of human studies. Sleep Med Rev 2014;18:477-487.
PubMed
Article
Google Scholar
Tramèr MR, Carroll D, Campbell FA, Reynolds DJM, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 2001;323:16.
PubMed Central
PubMed
Article
Google Scholar
Yamamoto I, Watanabe K, Matsunaga T, Kimura T, Funahashi T, Yoshimura H. Pharmacology and toxicology of major constituents of marijuana—on the metabolic activation of cannabinoids and its mechanism. Toxin Rev 2003;22:577-589.
CAS
Article
Google Scholar
Zhornitsky S, Potvin S. Cannabidiol in humans—the quest for therapeutic targets. Pharmaceuticals 2012;5:529-552.
PubMed Central
CAS
PubMed
Article
Google Scholar
Lynch ME, Campbell F. Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol 2011;72:735-744.
PubMed Central
CAS
PubMed
Article
Google Scholar
Roitman P, Mechoulam R, Cooper-Kazaz R, Shalev A. Preliminary, open-label, pilot study of add-on oral Delta9-tetrahydrocannabinol in chronic post-traumatic stress disorder. Clin Drug Investig 2014;34:587-591.
CAS
PubMed
Article
Google Scholar
Kobayashi H, Suzuki T, Kamata R, et al. Recent progress in the neurotoxicology of natural drugs associated with dependence or addiction, their endogenous agonists and receptors. J Toxicol Sci 1999;24:1-16.
CAS
PubMed
Article
Google Scholar
Crane NA, Schuster RM, Fusar-Poli P, Gonzalez R. Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev 2013;23:117-137.
PubMed Central
PubMed
Article
Google Scholar
Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci 2012;109:E2657-E2664.
PubMed Central
CAS
PubMed
Article
Google Scholar
Schoeler T, Bhattacharyya S. The effect of cannabis use on memory function: an update. Subst Abuse Rehabil 2013;4:11-27.
PubMed Central
PubMed
Google Scholar
Ehrler M, McGlade EC, Yurgelun-Todd D. Subjective and cognitive effects of cannabinoids in marijuana smokers. In: Campolongo P, Fattore L, editors. Cannabinoid modulation of emotion, memory, and motivation. New York: Springer; 2015. p. 159–181.
Wrege J, Schmidt A, Walter A, et al. Effects of cannabis on impulsivity: a systematic review of neuroimaging findings. Curr Pharm Des 2014;20:2126.
PubMed Central
CAS
PubMed
Article
Google Scholar
Crean RD, Crane NA, Mason BJ. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 2011;5:1.
PubMed Central
PubMed
Article
Google Scholar
Gonzalez R, Carey C, Grant I. Nonacute (residual) neuropsychological effects of cannabis use: a qualitative analysis and systematic review. J Clin Pharmacol 2002;42(Suppl.1):48S-57S.
CAS
PubMed
Article
Google Scholar
Solowij N, Pesa N. Cognitive abnormalities and cannabis use. Rev Bras Psiquiatr 2010;32:531-540.
Article
Google Scholar
Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun‐Todd D. Cognitive Measures in long‐term cannabis users. J Clin Pharmacol 2002;42(Suppl. 1):41S-47S.
CAS
PubMed
Article
Google Scholar
Pope Jr HG, Gruber AJ, Yurgelun-Todd D. Residual neuropsychologic effects of cannabis. Curr Psychiatry Rep 2001;3:507-512.
PubMed
Article
Google Scholar
Grant I, Gonzalez R, Carey CL, Natarajan L, Wolfson T. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc 2003;9:679-689.
CAS
PubMed
Article
Google Scholar
Schweinsburg AD, Brown SA, Tapert SF. The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev 2008;1:99.
PubMed Central
PubMed
Article
Google Scholar
James A, James C, Thwaites T. The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. Psychiatry Res 2013;214:181-189.
PubMed
Article
Google Scholar
Pope HG, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend 2003;69:303-310.
PubMed
Article
Google Scholar
Pope HG, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996;275:521-527.
CAS
PubMed
Article
Google Scholar
Batalla A, Bhattacharyya S, Yucel M, et al. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PloS One 2013;8:e55821.
PubMed Central
CAS
PubMed
Article
Google Scholar
Lorenzetti V, Lubman DI, Whittle S, Solowij N, Yucel M. Structural MRI findings in long-term cannabis users: what do we know? Substance Use Misuse 2010;45:1787-1808.
PubMed
Article
Google Scholar
Martin-Santos R, Fagundo AB, Crippa JA, et al. Neuroimaging in cannabis use: a systematic review of the literature. Psychol Med 2010;40:383-398.
CAS
PubMed
Article
Google Scholar
Rapp C, Bugra H, Riecher-Rössler A, Tamagni C, Borgwardt S. Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies. Curr Pharm Des 2012;18:5070.
PubMed Central
CAS
PubMed
Article
Google Scholar
Lopez-Larson MP, Bogorodzki P, Rogowska J, et al. Altered prefrontal and insular cortical thickness in adolescent marijuana users. Behav Brain Res 2011;220:164-172.
PubMed Central
PubMed
Article
Google Scholar
McCormick MA, Shekhar A. Review of marijuana use in the adolescent population and implications of its legalization in the United States. J Drug Metab Toxicol 2014;5:2.
Jacobus J, Squeglia LM, Meruelo AD, et al. Cortical thickness in adolescent marijuana and alcohol users: a three-year prospective study from adolescence to young adulthood. Dev Cog Neurosci 2015 Apr 27 [Epub ahead of print].
Wetherill RR, Jagannathan K, Hager N, Childress AR, Rao H, Franklin TR. Cannabis, cigarettes, and their co-occurring use: disentangling differences in gray matter volume. Int J Neuropsychopharmacol 2015:pyv061.
Gruber SA, Yurgelun-Todd DA. Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Cog Brain Res 2005;23:107-118.
Article
Google Scholar
Churchwell JC, Yurgelun-Todd DA. Neuroimaging, adolescence, and risky behavior. In: MT B, DH F, R M (eds) Inhibitory control and drug abuse prevention. Springer, ??, 2011, pp. 101-122.
Kanayama G, Rogowska J, Pope HG, Gruber SA, Yurgelun-Todd DA. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacol 2004;176:239-247.
CAS
Article
Google Scholar
Chang L, Cloak C, Yakupov R, Ernst T. Combined and independent effects of chronic marijuana use and HIV on brain metabolites. J Neuroimmune Pharmacol 2006;1:65-76.
CAS
PubMed
Article
Google Scholar
Hermann D, Sartorius A, Welzel H, et al. Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biol Psychol 2007;61:1281-1289.
CAS
Article
Google Scholar
Prescot AP, Renshaw PF, Yurgelun-Todd DA. γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers. Drug Alcohol Depend 2013;129:232-239.
CAS
PubMed
PubMed Central
Article
Google Scholar
Crippa JAS, Derenusson GN, Ferrari TB, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol 2011;25:121-130.
CAS
PubMed
Article
Google Scholar
Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh SP. Cannabis use and mania symptoms: a systematic review and meta-analysis. J Affect Disord 2015;171:39-47.
PubMed
Article
Google Scholar
Lev-Ran S, Roerecke M, Le Foll B, George TP, McKenzie K, Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med 2014;44:797-810.
CAS
PubMed
Article
Google Scholar
Crippa JA, Zuardi AW, Martin-Santos R, et al. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol 2009;24:515-523.
CAS
PubMed
Article
Google Scholar
Nussbaum AM, Thurstone C, McGarry L, Walker B, Sabel AL. Use and diversion of medical marijuana among adults admitted to inpatient psychiatry. Am J Drug Alcohol Abuse 2015;41:166-172.
PubMed
Article
Google Scholar
Ferretjans R, Moreira FA, Teixeira AL, Salgado JV. The endocannabinoid system and its role in schizophrenia: a systematic review of the literature. Rev Bras Psiquiatr 2012;34:163-193.
Article
Google Scholar
Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005;19:187-194.
PubMed
Article
Google Scholar
Moore THM, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007;370:319-328.
PubMed
Article
Google Scholar
Szoke A, Galliot AM, Richard JR, et al. Association between cannabis use and schizotypal dimensions—a meta-analysis of cross-sectional studies. Psychiatry Res 2014;219:58-66.
PubMed
Article
Google Scholar
Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur Arch Psychiatry Clin 2013;263:3-13.
Article
Google Scholar
J van der Meer F, Velthorst E, J Meijer C, WJ Machielsen M, de Haan L. Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis. Curr Pharm Des 2012;18:5036-5044.
Iseger TA, Bossong MG. A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophr Res 2015;162:153-161.
PubMed
Article
Google Scholar
Roser P, S Haussleiter I. Antipsychotic-like effects of cannabidiol and rimonabant: systematic review of animal and human studies. Curr Pharm Des 2012;18:5141-5155.
Calabria B, Degenhardt L, Hall W, Lynskey M. Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev 2010;29:318-330.
PubMed
Article
Google Scholar
Johnston LD, Miech RA, O'Malley PM, Bachman JG, Schulenberg JE. Use of alcohol, cigarettes, and number of illicit drugs declines among U.S. teens. Ann Arbor, MI, 2014/ Retrieved 20 Apr. 2015. Report No.
National Intstitute of Drug Abuse (NIDA). Research Report Series: Marijuana. 2015.
Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000;22:325-336.
CAS
PubMed
Article
Google Scholar
Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol 2002;24:309-320.
CAS
PubMed
Article
Google Scholar
de Moraes Barros MC, Guinsburg R, Mitsuhiro S, Chalem E, Laranjeira RR. Neurobehavioral profile of healthy full-term newborn infants of adolescent mothers. Early Hum Dev 2008;84:281-287.
PubMed
Article
Google Scholar
Fried PA, Makin J. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicol Teratol 1987;9:1-7.
CAS
PubMed
Article
Google Scholar
Mincis M, Pfeferman A, Guimarães R, Ramos O, Zukerman E, Karniol I, et al. [Chronic administration of cannabidiol in man. Pilot study]. AMB Rev Assoc Med Bras 1973;19:185-190 (in Portuguese).
CAS
PubMed
Google Scholar
Koppel BS, Brust JC, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014;82:1556-1563.
PubMed Central
PubMed
Article
Google Scholar
Lakhan SE, Rowland M. Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurol 2009;9:59.
PubMed Central
PubMed
Article
CAS
Google Scholar
O’Reilly K. AMA meeting: delegates support review of marijuana’s schedule I status. American Medical New [Internet] 2009. [cited 2015 Apr 20]. Available from: http://www.amednews.com/article/20091123/profession/311239968/7/
Wade DT, Makela P, House H, Bateman C, Robson P. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Multiple Sclerosis 2006;12:639-645.
CAS
PubMed
Article
Google Scholar
Pavisian B, MacIntosh BJ, Szilagyi G, Staines RW, O'Connor P, Feinstein A. Effects of cannabis on cognition in patients with MS A psychometric and MRI study. Neurology 2014;82:1879-1887.
PubMed Central
PubMed
Article
Google Scholar
Honarmand K, Tierney MC, O'Connor P, Feinstein A. Effects of cannabis on cognitive function in patients with multiple sclerosis. Neurololgy 2011;76:1153-1160.
Article
Google Scholar
Ghaffar O, Feinstein A. Multiple sclerosis and cannabis: a cognitive and psychiatric study. Neurology 2008;71:164-169.
CAS
PubMed
Article
Google Scholar
Gloss D, Vickrey B. Cannabinoids for epilepsy. Cochrane Database Syst Rev 2012;6:CD009270.
PubMed
Google Scholar
Krishnan S, Cairns R, Howard R. Cannabinoids for the treatment of dementia. Cochrane Database Syst Rev 2009;(2):CD007204.
PubMed
Google Scholar
Solas M, Francis PT, Franco R, Ramirez MJ. CB 2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients. Neurobiol Aging 2013;34:805-808.
CAS
PubMed
Article
Google Scholar
Esposito G, De Filippis D, Carnuccio R, Izzo AA, Iuvone T. The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells. J Mol Med 2006;84:253-258.
CAS
PubMed
Article
Google Scholar
Eubanks LM, Rogers CJ, Beuscher AE, IV, et al. A molecular link between the active component of marijuana and Alzheimer's disease pathology. Mol Pharm 2006;3:773-777.
PubMed Central
CAS
PubMed
Article
Google Scholar
Fox SH, Henry B, Hill M, Crossman A, Brotchie J. Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's disease. Mov Disord 2002;17:1180-1187.
PubMed
Article
Google Scholar
Sagredo O, Ruth Pazos M, Valdeolivas S, Fernández-Ruiz J. Cannabinoids: novel medicines for the treatment of Huntington's disease. Recent Pat CNS Drug Discov 2012;7:41-48.
CAS
PubMed
Article
Google Scholar
McLoughlin BC, Pushpa‐Rajah JA, Gillies D, et al. Cannabis and schizophrenia. Cochrane Database Syst Rev 2014;10:CD004837.
PubMed
Google Scholar
Zuardi AW, Hallak JE, Dursun SM, et al. Cannabidiol monotherapy for treatment-resistant schizophrenia. J Psychopharmacol 2006;20:683-686.
CAS
PubMed
Article
Google Scholar
Boychuk DG, Goddard G, Mauro G, Orellana MF. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review. J Oral Facial Pain Headache 2015;29:7-14.
PubMed
Article
Google Scholar
Eisenberg E, Ogintz M, Almog S. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study. J Pain Palliat Care Pharmacother 2014;28:216-225.
PubMed
Article
Google Scholar
Martin-Sanchez E, Furukawa TA, Taylor J, Martin JL. Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Med 2009;10:1353-1368.
PubMed
Article
Google Scholar
Richards BL, Whittle SL, Buchbinder R. Neuromodulators for pain management in rheumatoid arthritis. Cochrane Database Syst Rev 2012;1:CD008921.
PubMed
Google Scholar
Canadian Agency for Drugs and Technologies in Health (CADTH). CADTH rapid response reports. CADTH, Ottawa, 2014.
Google Scholar
Machado Rocha FC, Stefano SC, De Cassia Haiek R, Rosa Oliveira LM, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care 2008;17:431-443.
CAS
Article
Google Scholar
Wang T, Collet JP, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. CMAJ 2008;178:1669-1678.
PubMed Central
PubMed
Article
Google Scholar
Mack A, Joy J. Marijuana as medicine?: the science beyond the controversy: National Academies Press, 2000.
Kassirer JP. Federal foolishness and marijuana. N Engl J Med 1997;336:366.
CAS
PubMed
Article
Google Scholar
Lopez-Pelayo H, Batalla A, Balcells MM, Colom J, Gual A. Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. Psychol Med 2015;45:1121-1133.
CAS
PubMed
Article
Google Scholar
Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2012 National Survey on Drug Use and Health: summary of national findings. Substance Abuse and Mental Health Services Administration, Rockville, MD, 2013.
Google Scholar
Okaneku J, Vearrier D, McKeever RG, LaSala GS, Greenberg MI. Change in perceived risk associated with marijuana use in the United States from 2002 to 2012. Clin Toxicol 2015;53:151-155.
Article
Google Scholar
Research PHL. Laws, maps & data: law atlas. Robert Wood Johnson Foundation.
Pacula RL, Hunt P, Boustead A. Words can be deceiving: a review of variation among legally effective medical marijuana laws in the United States. J Drug Policy Anal 2014;7:1-19.
PubMed Central
PubMed
Article
Google Scholar
Blumenson E, Nilsen E. No rational basis: the pragmatic case for marijuana law reform. Va J Soc Pol'y & L. 2009;17:43.
Google Scholar
Bostwick JM. Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc 2012;87:172-186.
PubMed Central
PubMed
Article
Google Scholar
Bostwick JM. The use of cannabis for management of chronic pain. Gen Hosp Psychiatry 2014;36:2-3.
PubMed
Article
Google Scholar
Cohen PJ. Medical marijuana 2010: it's time to fix the regulatory vacuum. J Law Med Ethics 2010;38:654-666.
PubMed
Article
Google Scholar
Caulkins JP, Hawken A, Kilmer B, Kleiman MA. Marijuana Legalization: what everyone needs to know. Oxford, Oxford University Press, 2012.
Google Scholar
Kilmer B. Policy designs for cannabis legalization: starting with the eight Ps. Am J Drug Alcohol Ab 2014;40:259-261.
Caulkins JP, Hawken A, Kilmer B, Kleiman MA. High tax states: options for gleaning revenue from legal cannabis. Or L Rev 2012;91:1041.
Google Scholar